HomeNews

News

  • Epidiolex approved by FDA for severe forms of epilepsy

    • June 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Oromucosal Cannabinoid Spray reduces pain in MS patients, study finds

    • June 26, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA expediates approval process for Voyager’s Parkinson’s drug by granting RMAT designation

    • June 25, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Herpesvirus may cause Alzheimer’s and also lead to its progression, study finds

    • June 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • NICE approves Ocrevus in RRMS but with certain conditions

    • June 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Alder to present new data for Eptinezumab at American Headache Society Meeting

    • June 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Publication on novel Technology for Zolmitriptan in Migraine, announced by Zosano

    • June 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Phase 1 trial announced for a potential MS drug RTA 1701

    • June 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Series A Financing raised for Epilepsy Drug-Device Combination Therapy

    • June 22, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • New Anti Epileptic drug launched in the US market by Dr Reddy’s

    • June 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more